All Stories

Executive Interviews at Fierce Pharma Engage 2025

Join Fierce Pharma as we sit down with industry innovators to explore the most impactful strategies, cutting-edge insights, and collaborative approaches shaping the future of pharma engagement.

Jun 2, 2025 - 13:35
 0
Executive Interviews at Fierce Pharma Engage 2025
Join Fierce Pharma as we sit down with industry innovators to explore the most impactful strategies, cutting-edge insights, and collaborative approaches shaping the future of pharma engagement.
Read More

Tags:

Previous Article

ASCO: AstraZeneca, Daiichi flex Enhertu's muscles in first-line breast cancer as...

Next Article

The Multimodal Imperative: How AI-Driven Technology is Driving Impactful Changes

Related Posts

'Hanging on by our fingernails': Stealth CEO questions efficiency behind FDA rejection of rare disease drug

'Hanging on by our fingernails': Stealth CEO questions ...

May 29, 2025  0

ASCO: J&J highlights Rybrevant-Lazcluze combo in 'Breathtaking Moments' lung cancer campaign high over Chicago skyline

ASCO: J&J highlights Rybrevant-Lazcluze combo in 'Breat...

Jun 3, 2025  0

AstraZeneca's Airsupra cuts risk of severe exacerbations by 47% in patients with milder asthma

AstraZeneca's Airsupra cuts risk of severe exacerbation...

May 19, 2025  0